Allergan plc
https://www.allerganaesthetics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Allergan plc
Lilly Adds To Radiopharma Arsenal With Option To Buy Radionetics
Lilly paid $140m up front for an option to acquire Radionetics for $1bn within an undisclosed timeframe. The private firm is developing small molecule GPCR-targeted radiopharmaceuticals.
Poland’s Quiet Pivot From Generics To Innovative Treatments
Poland is slowly expanding beyond its position as a central European generics hub. More established companies are adding innovative medicine pipelines and a small number of biotechs are making international deals.
The View From The Top: European CEOs Highlight Industry Priorities
At a high-profile panel closing out Medicines for Europe’s 30th annual conference in Dublin, six industry leaders set out their views on key topics including pricing, regulation, sustainability, and stakeholder communication.
BIO Notebook: FDA User Fees For AI Regulation, Partnering Strategy Evolves, And More
Insights from Day Two of the BIO International Convention in San Diego include the evolving pros and cons of partnering, user fees potentially supporting the FDA's AI ambitions, and J&J's view on dealmaking in 2024.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- OTC, Consumer
- Specialty Pharmaceuticals
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Actavis, Inc.
- Actavis plc
- Akarna Therapeutics Ltd.
- Allergan Aesthetics
- Allergan, Inc.
- Anterios, Inc.
- Arrow Group (Subsidiaries: Arrow Generics (U.K), Cobalt Group (U.S.))
- AqueSys, Inc.
- Bonti, Inc.
- Chase Pharmaceuticals Corporation, Inc.
- Durata Therapeutics
- Elastagen Pty Ltd
- EndoArt SA
- Envy Medical, Inc.
- Forest Laboratories [Aptalis Pharmaceutical Technologies
- (Axcan Pharma, Inc.
- Eurand N.V.
- Mpex Pharmaceuticals, Inc.)
- Cerexa, Inc.
- Clinical Data, Inc.]
- Furiex Pharmaceuticals, Inc. (PPD, Inc.)
- Kythera Biopharmaceuticals, Inc.
- MAP Pharmaceuticals
- Motus Therapeutics, Inc. (Rhythm Health, Inc.)
- Naurex, Inc.
- Oculeve
- Regado Biosciences, Inc.
- RetroSense Therapeutics, LLC
- Silom Medical Company
- Uteron Pharma SA
- Warner Chilcott PLC (Galen Holdings PLC)
- Watson Pharmaceuticals, Inc.
- Tobira Therapeutics, Inc.
- Topokine Therapeutics
- Vitae Pharmaceuticals, Inc.
- ForSight VISION5, Inc.
- LifeCell Corporation
- ZELTIQ Aesthetics, Inc.
- Zonagen, Inc.
- Repros Therapeutics, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice